Creative Financial Designs’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.7K Buy
69
+68
+6,800% +$12.5K ﹤0.01% 1342
2025
Q4
$176 Hold
1
﹤0.01% 2016
2025
Q3
$140 Hold
1
﹤0.01% 2014
2025
Q2
$126 Buy
+1
New +$125 ﹤0.01% 1974
2024
Q1
Sell
-12
Closed -$3.1K 1672
2023
Q4
$3.1K Hold
12
﹤0.01% 1350
2023
Q3
$3.08K Hold
12
﹤0.01% 1270
2023
Q2
$3.42K Sell
12
-22
-65% -$6.55K ﹤0.01% 1239
2023
Q1
$9.45K Sell
34
-1
-3% -$277 ﹤0.01% 972
2022
Q4
$9.69K Buy
35
+5
+17% +$1.41K ﹤0.01% 906
2022
Q3
$8K Hold
30
﹤0.01% 923
2022
Q2
$6K Sell
30
-152
-84% -$31.1K ﹤0.01% 958
2022
Q1
$38K Sell
182
-9,894
-98% -$2.15M 0.01% 613
2021
Q4
$2.42M Buy
10,076
+1,671
+20% +$430K 0.36% 61
2021
Q3
$2.38M Buy
8,405
+862
+11% +$283K 0.39% 59
2021
Q2
$2.61M Buy
7,543
+1,061
+16% +$321K 0.45% 50
2021
Q1
$1.81M Buy
6,482
+1,573
+32% +$424K 0.35% 65
2020
Q4
$1.2M Buy
4,909
+1,238
+34% +$319K 0.26% 75
2020
Q3
$1.04M Buy
3,671
+3,411
+1,312% +$951K 0.26% 76
2020
Q2
$70K Buy
+260
New +$78.2K 0.02% 360
2019
Q1
Sell
-6
Closed -$2K 565
2018
Q4
$2K Sell
6
-3
-33% -$957 ﹤0.01% 499
2018
Q3
$3K Sell
9
-53
-85% -$18.2K ﹤0.01% 590
2018
Q2
$18K Buy
62
+37
+148% +$10.4K 0.01% 375
2018
Q1
$7K Hold
25
﹤0.01% 451
2017
Q4
$8K Buy
+25
New +$8.02K 0.01% 434

Other funds holding BIIB

Creative Financial Designs's BIIB Position: Q1 2026 in Review

Creative Financial Designs increased its Biogen (BIIB) stake by 6,800% in Q1 2026, buying an estimated $12.5K and bringing the position to 69 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1342.

Creative Financial Designs first reported a position in BIIB in Q4 2017 and has held it in 24 quarters since. The position peaked at $2.61M in Q2 2021. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Creative Financial Designs held 69 shares of Biogen worth $12.7K as of Q1 2026.
  • Creative Financial Designs bought 68 Biogen shares in Q1 2026, an estimated $12.5K.
  • Biogen made up ﹤0.01% of Creative Financial Designs's portfolio in Q1 2026, its #1342 holding.
  • Creative Financial Designs first reported a position in Biogen in Q4 2017 and has held it in 24 quarters since.
  • Creative Financial Designs's Biogen position peaked at $2.61M in Q2 2021.
  • 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.